Denmark allows unapproved pill for at-risk Covid-19 patients in line with EMA advice
The European Medicines Agency has issued advice pertaining to the emergency use of the unapproved MSD's Covid-19 tablet treatment, Lagevrio (molnupiravir) – the Danish Health Authority is now allowing treatment with the drug in Denmark.
by MIKKEL AABENHUS HEMMINGSEN, translated by daniel pedersen
The Danish Health Authority is now allowing Danish doctors to use MSD's tablet treatment, Lagevrio (molnupiravir), to treat Covid-19 patients, despite the drug having yet to be formally approved by the European Medicines Agency (EMA), the Danish authority reports in a press release.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
EMA allows emergency use of MSD's Covid-19 capsule treatment
For subscribers
EMA to investigate Covid-19 treatment
For subscribers
EMA: Omicron cases appear "mostly mild"
For subscribers
.jpg&w=384&q=75)
